Gx Acquisiton Corp Cl A (GXGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | GXGX | EDIT | FATE | ||
Company | Gx Acquisiton Corp Cl A | Editas Medicine | Fate Therapeutics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 8.18 | 4.60 | 3.21 | ||
High | 12.58 | 4.74 | 3.36 | ||
Low | 8.07 | 4.56 | 3.14 | ||
Last | 10.20 | 4.66 | 3.16 | ||
Change | +2.18 | +0.12 | -0.06 | ||
% Change | +27.18% | +2.64% | -1.86% | ||
Volume | 17,319,200 | 988,041 | 581,507 | ||
20-Day Average Volume | 1,188,490 | 2,595,987 | 2,063,985 | ||
Previous Close | 8.02 | 4.54 | 3.22 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 10.00 | 5.10 | 3.57 | ||
20-Day Raw Stochastic | 50.93% | 11.86% | 6.36% | ||
20-Day Relative Strength | 52.40% | 39.25% | 35.35% | ||
Weighted Alpha | -0.69 | -63.14 | -58.04 | ||
Today's Opinion | 56% Sell | 100% Sell | 88% Sell | ||
Previous Opinion | 100% Sell | 100% Sell | 88% Sell | ||
Last Month's Opinion | 8% Sell | 100% Sell | 56% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -0.10% since 07/09/21 | -3.12% since 06/26/24 | -3.07% since 06/26/24 | ||
Low | 7.73 on 07/15/21 | 4.45 on 07/02/24 | 3.09 on 07/02/24 | ||
High | 12.58 on 07/16/21 | 4.86 on 07/01/24 | 3.39 on 07/01/24 | ||
1-Month | |||||
%Chg | +0.29% since 06/16/21 | -13.86% since 06/03/24 | -13.90% since 06/03/24 | ||
Low | 7.73 on 07/15/21 | 4.45 on 07/02/24 | 3.09 on 07/02/24 | ||
High | 12.58 on 07/16/21 | 6.22 on 06/12/24 | 4.19 on 06/12/24 | ||
3-Month | |||||
%Chg | +0.99% since 04/16/21 | -32.07% since 04/03/24 | -54.92% since 04/03/24 | ||
Low | 7.73 on 07/15/21 | 4.45 on 07/02/24 | 3.09 on 07/02/24 | ||
High | 12.58 on 07/16/21 | 7.09 on 04/04/24 | 7.34 on 04/04/24 | ||
6-Month | |||||
%Chg | -2.86% since 01/15/21 | -50.79% since 01/03/24 | -10.73% since 01/03/24 | ||
Low | 7.73 on 07/15/21 | 4.45 on 07/02/24 | 3.09 on 07/02/24 | ||
High | 12.58 on 07/16/21 | 11.58 on 02/28/24 | 8.83 on 03/07/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 366,557 | 373,360 | 366,539 | ||
Shares Outstanding, K | 35,937 | 82,238 | 113,832 | ||
Annual Sales | 0 | 78,120,000 | 63,530,000 | ||
Annual Net Income | -2,630,000 | -153,220,000 | -160,930,000 | ||
Last Quarter Sales | 0 | 1,140,000 | 1,930,000 | ||
Last Quarter Net Income | 38,028,962 | -61,950,000 | -48,000,000 | ||
60-Month Beta | 0.17 | 2.01 | 1.90 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.76 on 05/08/24 | -0.47 on 05/09/24 | ||
Latest Earnings Date | N/A | 08/07/24 | 08/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |